首页> 美国卫生研究院文献>BMC Public Health >The speed of adoption of new drugs and prescription volume after the amendments in reimbursement coverage: the case of non-vitamin K antagonist oral anticoagulants in South Korea

【2h】

The speed of adoption of new drugs and prescription volume after the amendments in reimbursement coverage: the case of non-vitamin K antagonist oral anticoagulants in South Korea

机译：报销范围修正后新药的采用速度和处方量：以韩国非维生素K拮抗剂口服抗凝药为例

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The regulatory approval and reimbursement process of NOACs in the South Korean market

机译：NOAC在韩国市场的监管审批和报销流程

著录项

期刊名称 BMC Public Health
作者
Kyung-Bok Son;
展开▼
作者单位

展开▼
年(卷),期 2020(20),-1
年度 2020
页码 -1
总页数 11
原文格式 PDF
正文语种
中图分类公共卫生工程;
关键词
Adoption of new drugs; Reimbursement coverage; Pharmaceutical expenditure; Pharmaceutical policy; South Korea;

机译：采用新药;报销范围;药品支出;药品政策;韩国;

相似文献

外文文献
中文文献
专利

1. The speed of adoption of new drugs and prescription volume after the amendments in reimbursement coverage: the case of non-vitamin K antagonist oral anticoagulants in South Korea [J] . Kyung-Bok Son BMC Public Health . 2020,第1期

机译：报销覆盖率修正后新药和处方量的采用速度：韩国非维生素K拮抗剂口腔抗凝血剂的案例
2. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group [J] . Pharithi Rebabonye B., Ranganathan Deepti, OBrien Jim, Irish journal of medical science . 2019,第1期

机译：处方是否正确？非瓣膜心房颤动患者的非维生素K拮抗剂抗凝血剂（NOAC）处方述评。心房颤动和卒中中非维生素K口腔抗凝血剂的心房颤动和评价安全规定（安全Noacs）组
3. PRESCRIPTION TREND AND DRUG ADHERENCE OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION [J] . Han S., Jeong H. S., Kim H. T., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：非维生素K拮抗剂口腔抗凝剂在老年心房颤动患者中的处方趋势和药物依从性
4. Switching from Vitamin K Antagonists to Non-vitamin K Oral Anticoagulants, Drug-Drug Interactions, and Health Outcomes among Working-Age Adults with Atrial Fibrillation [D] . Feng, Xue. 2018

机译：从维生素K拮抗剂切换到非维生素K口服抗凝剂，药物 - 药物相互作用，以及具有心房颤动的工作年龄成年人之间的健康状况
5. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis [O] . Giuseppe Santarpia, Salvatore De Rosa, Alberto Polimeni, -1

机译：非维生素K拮抗剂口服抗凝剂和维生素K拮抗剂口服抗凝剂在房颤射频导管消融患者中的疗效和安全性：一项荟萃分析
6. Analysis of Recurrent Stroke Volume Between VKA (Vitamin K Antagonist) and Three NOACs (Non-Vitamin K Antagonist Oral Anticoagulants) Under Oral Anticoagulant Therapy [O] . Hiroaki Oguro, Ryo Mizuhara, Satoshi Abe, 2016

机译：在口服抗凝治疗下VKA（维生素K拮抗剂）和三种敲击（非维生素K拮抗剂口腔抗凝剂）之间的复发性卒中体积分析

The speed of adoption of new drugs and prescription volume after the amendments in reimbursement coverage: the case of non-vitamin K antagonist oral anticoagulants in South Korea

摘要

著录项

相似文献

相关主题

期刊订阅